Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Lucía Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Míriam Rosás-Umbert, Mariona Parera, María Casadellà, Miriam Cebey‐López, Francisco Pérez, Bruna Oriol-Tordera, Marta Ruiz‐Riol, J Coll, Fèlix Pérez, Àngel Rivero, Anne R. Leselbaum, Ian McGowan, Devi SenGupta, Edmund G. Wee, Tomáš Hanke, Roger Paredes, Yovaninna Alarcón‐Soto, Bonaventura Clotet, Marc Noguera-Julián, Christian Brander, José Moltó, Beatriz Mothe, the AELIX002 Study Group, Ana María Barriocanal, Susana Benet, Patricia Cobarsí, Romas Geleziunas, Anne R. Leselbaum, Cora Loste, Michael Meulbroek, Cristina Miranda, José F. Muñoz, Jordi Naval, Aroa Nieto, Ferran Pujol, Jordi Puig